Data & Images
|Product Name||Anti-LTK Antibody|
|Description||Rabbit IgG polyclonal antibody for Leukocyte tyrosine kinase receptor(LTK) detection. Tested with WB in Human.|
|Cite This Product||Anti-LTK Antibody (Boster Biological Technology, Pleasanton CA, USA, Catalog # PA1990)|
|Replacement Item||This antibody may replace the following items: sc-6351|sc-6350|sc-367583|sc-393465 from Santa Cruz Biotechnology.|
*Our Boster Guarantee covers the use of this product in the above tested applications.
**For positive and negative control design, consult "Tissue specificity" under Protein Target Info.
|Recommended Detection Systems||Boster recommends Enhanced Chemiluminescent Kit with anti-Rabbit IgG (EK1002) for Western blot.
*Blocking peptide can be purchased at $50. Contact us for more information
**Boster also offers various secondary antibodies for Immunoflourescecne and IHC. Take advantage of the buy 1 primary antibody get 1 secondary antibody for free promotion for the entire year 2017!
|Immunogen||A synthetic peptide corresponding to a sequence at the C-terminus of human LTK(850-864aa RGLQPQNLWNPTYRS).|
|Cross Reactivity||No cross reactivity with other proteins|
|Contents||Each vial contains 5mg BSA, 0.9mg NaCl, 0.2mg Na2HPO4, 0.05mg Thimerosal, 0.05mg NaN3.
*carrier free antibody available upon request.
|Concentration||Add 0.2ml of distilled water will yield a concentration of 500ug/ml.|
|Storage||At -20˚C for one year. After reconstitution, at 4˚C for one month. It can also be aliquotted and stored frozen at -20˚C for a longer time.Avoid repeated freezing and thawing.|
|Purification||Immunogen affinity purified.|
Protein Target Info (Source: Uniprot.org)
You can check the tissue specificity below for information on selecting positive and negative control.
|Protein Name||Leukocyte tyrosine kinase receptor|
|Molecular Weight||91681 MW|
|Protein Function||Orphan receptor with a tyrosine-protein kinase activity. The exact function of this protein is not known. Studies with chimeric proteins (replacing its extracellular region with that of several known growth factor receptors, such as EGFR and CSFIR) demonstrate its ability to promote growth and specifically neurite outgrowth, and cell survival. Signaling appears to involve the PI3 kinase pathway. Involved in regulation of the secretory pathway involving endoplasmic reticulum (ER) export sites (ERESs) and ER to Golgi transport. .|
|Tissue Specificity||Expressed in non-hematopoietic cell lines and T- and B-cell lines. .|
|Sequence Similarities||Belongs to the protein kinase superfamily. Tyr protein kinase family. Insulin receptor subfamily.|
|Subcellular Localization||Membrane; Single-pass type I membrane protein.|
|Alternative Names||Leukocyte tyrosine kinase receptor;18.104.22.168;Protein tyrosine kinase 1;LTK;TYK1;|
|Research Areas|||signal transduction|protein phosphorylation|tyrosine kinases| signal transduction|receptor tyrosine kinases|growth factors/hormones|insulin / insulin-like|metabolism|energy metabolism| metabolism|pathways and processes|metabolic signaling pathways|energy transfer pathways||
Background for Leukocyte tyrosine kinase receptor
Dilution Ratios/Recommended Concentrations
At Boster we strive to provide the best Anti-LTK Antibody by testing all applications on non-spiked tissues and cell lines to ensure that the affinity of the antibody is enough to react to the endogenouse level of the target protein. Read more about our QC panel here.
|Recommended dilution ratios are listed below:|
Western blot, 0.1-0.5μg/ml, Human|
**Boster provides high sensitivity secondary antibody kits for Western blotting and IHC. For more info see Related Products below.
Anti-LTK Antibody Images
Click the images to enlarge.
Recombinant Protein Detection Source: E.coli derived -recombinant Human LTK,33.1KD (162aa tag+ N729-S864)
Lane 1: Recombinant Human LTK Protein 10ng
Lane 2: Recombinant Human LTK Protein 5ng
Lane 3: Recombinant Human LTK Protein 2.5ng
Lane 4: Recombinant Human LTK Protein 1.25ng
1. Post-translational modification:phosphorylation, methylation, glycosylation etc. These modifications prevent SDS molecules from binding to the target protein and thus make the band size appear larger than expected
2. Post-translational cleavage: this can cause smaller bands and or multiple bands
3. Alternative splicing: the same gene can have alternative splicing patterns generating different size proteins, all with reactivities to the antibody.
4. Amino Acid R chain charge: SDS binds to positive charges. The different size and charge of the Amino Acid side chains can affect the amount of SDS binding and thus affect the observed band size.
5. Multimers: Multimers are usually broken up in reducing conditions. However if the interactions between the multimers are strong, the band may appear higher.,